Altamira Therapeutics Correlations
CYTO Stock | USD 0.43 0.01 2.38% |
The current 90-days correlation between Altamira Therapeutics and Eliem Therapeutics is -0.1 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Altamira Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Altamira Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Altamira |
Moving together with Altamira Stock
0.71 | ME | 23Andme Holding | PairCorr |
0.92 | VALN | Valneva SE ADR | PairCorr |
0.75 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.88 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.76 | IPSC | Century Therapeutics | PairCorr |
0.81 | MTEM | Molecular Templates | PairCorr |
0.92 | NKTX | Nkarta Inc | PairCorr |
0.76 | TPST | Tempest Therapeutics | PairCorr |
0.87 | AGL | agilon health Buyout Trend | PairCorr |
0.84 | BACK | IMAC Holdings | PairCorr |
0.74 | CYRX | Cryoport | PairCorr |
0.74 | SHG | Shinhan Financial | PairCorr |
0.88 | EC | Ecopetrol SA ADR | PairCorr |
0.7 | HYMTF | Hyundai Motor | PairCorr |
0.7 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Altamira Stock
0.66 | KZR | Kezar Life Sciences | PairCorr |
0.55 | MLYS | Mineralys Therapeutics, | PairCorr |
0.39 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.92 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.89 | T | ATT Inc Aggressive Push | PairCorr |
0.85 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.83 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.81 | HD | Home Depot | PairCorr |
0.79 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.78 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.77 | HPQ | HP Inc | PairCorr |
0.64 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
0.55 | VFS | VinFast Auto Earnings Call Tomorrow | PairCorr |
0.48 | KB | KB Financial Group | PairCorr |
0.45 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
0.44 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.37 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
-0.01 | 0.87 | -0.52 | 0.83 | -0.66 | ELYM | ||
-0.01 | -0.17 | 0.1 | 0.11 | 0.01 | HCWB | ||
0.87 | -0.17 | -0.52 | 0.72 | -0.57 | SCPH | ||
-0.52 | 0.1 | -0.52 | -0.42 | 0.49 | MIST | ||
0.83 | 0.11 | 0.72 | -0.42 | -0.6 | MCRB | ||
-0.66 | 0.01 | -0.57 | 0.49 | -0.6 | LUMO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Altamira Stock performing well and Altamira Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Altamira Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 3.92 | (0.95) | 0.00 | (5.36) | 0.00 | 6.21 | 34.87 | |||
HCWB | 13.22 | 4.45 | 0.42 | (1.48) | 7.39 | 22.00 | 352.85 | |||
SCPH | 2.68 | (0.82) | 0.00 | (0.32) | 0.00 | 4.30 | 20.70 | |||
MIST | 1.92 | 0.21 | 0.13 | 0.25 | 1.60 | 7.19 | 18.66 | |||
MCRB | 4.68 | 0.01 | (0.02) | 0.25 | 5.68 | 10.00 | 28.84 | |||
LUMO | 2.77 | 0.61 | 0.15 | (3.14) | 2.60 | 6.35 | 26.13 |
Altamira Therapeutics Corporate Management
Covadonga Paeda | Chief Officer | Profile | |
Covadonga Paneda | Chief Officer | Profile | |
Jean Lechance | Unit Bus | Profile | |
Samuel MD | Chief Officer | Profile | |
Marcel CPA | Chief Officer | Profile |